| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
CEO | President &CEO | Director
1 company
Gaslightwala Abizer is a CEO at AKTX. Recent filings cover 7 purchases and 0 sales. Those positions are worth an estimated $13 at current prices.
Our model assigns Gaslightwala Abizer a strong insider score of 73/100, based on 7 past trades. Over a 12-month horizon, 100.0% of those trades were profitable, with an average 12-month return of +100.0%.
Gaslightwala Abizer's largest disclosed position is in AKTX as CEO, worth about $13. Net of sales, the recent Form 4 record there shows accumulation of 52,146 shares.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Aug 25, 2025 | AKTX Akari Therapeutics Plc | CEO | Buy | 21,000 | $0.93 | $19,540.00 | +7.6% | -50.0% | - | |
| Jun 24, 2025 | AKTX Akari Therapeutics Plc | President &CEO | Buy | 6,146 | $1.16 | $7,119.93 | +2.3% | -29.4% | +827.2% | |
| Jun 20, 2025 | AKTX Akari Therapeutics Plc | President &CEO | Buy | 10,000 | $1.20 | $12,000.00 | +3.8% | -28.6% | +902.7% | |
| Jun 17, 2025 | AKTX Akari Therapeutics Plc | President &CEO | Buy | 15,000 | $1.20 | $18,000.00 | +6.1% | -34.3% | +916.9% |